Sloan-Kettering Cancer Center Memorial, 10% Owner at Actinium Pharmaceuticals, Inc. (ATNM), sold 231,371 shares at $2.00 ($470K) on 2016-04-19, disclosed to the SEC on 2016-04-21.
Open-market sale of $470k ATNM by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.00 | 49,509 | $99K | 21.1% |
| 2 | $2.00 | 375 | $750 | 0.2% |
| 3 | $2.00 | 7,562 | $15K | 3.2% |
| 4 | $2.00 | 7,562 | $15K | 3.2% |
| 5 | $2.00 | 375 | $751 | 0.2% |
| 6 | $2.00 | 500 |
| $1K |
| 0.2% |
| 7 | $2.01 | 500 | $1K | 0.2% |
| 8 | $2.01 | 11,751 | $24K | 5.0% |
| 9 | $2.02 | 2,500 | $5K | 1.1% |
| 10 | $2.03 | 2,500 | $5K | 1.1% |
| 11 | $2.04 | 4,800 | $10K | 2.1% |
| 12 | $2.05 | 300 | $615 | 0.1% |
| 13 | $2.05 | 33,300 | $68K | 14.5% |
| 14 | $2.05 | 300 | $615 | 0.1% |
| 15 | $2.06 | 18,200 | $37K | 8.0% |
| 16 | $2.06 | 18,200 | $37K | 8.0% |
| 17 | $2.06 | 8,633 | $18K | 3.8% |
| 18 | $2.06 | 4,517 | $9K | 2.0% |
| 19 | $2.07 | 2,133 | $4K | 0.9% |
| 20 | $2.07 | 3,420 | $7K | 1.5% |
| 21 | $2.07 | 4,517 | $9K | 2.0% |
| 22 | $2.07 | 3,420 | $7K | 1.5% |
| 23 | $2.00 | 600 | $1K | 0.3% |
| 24 | $2.01 | 200 | $402 | 0.1% |
| 25 | $2.02 | 4,000 | $8K | 1.7% |
| 26 | $2.03 | 18,224 | $37K | 7.9% |
| 27 | $2.04 | 10,473 | $21K | 4.5% |
| 28 | $2.04 | 9,300 | $19K | 4.0% |
| 29 | $2.05 | 3,700 | $8K | 1.6% |
| Total | $2.03 avg | 231,371 | $470K | 100% |
| Filing → |
| ATNM | SELL | 2016-08-17 | $17K | — | Filing → |
| ATNM | SELL | 2016-07-14 | $6K | — | Filing → |
| ATNM | SELL | 2016-07-12 | $40K | — | Filing → |